Led · Series A · Aug 2026

MaxQ Medical is developing a fully automated, urethra-preserving transurethral ultrasound imaging and targeted therapy platform that combines advanced imaging with tissue-selective therapy in a single outpatient procedure. The system is intended to give urologists full visibility inside the prostate and enable treatment of visualized disease while minimizing urethral injury, swelling, bleeding, and sexual side effects. The company's initial indication is benign prostate hyperplasia (BPH), with planned expansion into focal therapy for prostate cancer and broader prostate diagnostics including biopsy and tumor mapping. MaxQ is the first spinout from Orchard Ultrasound Innovation and is based in Sunnyvale, California. The MaxQ System is investigational and not currently available for commercial use in the United States. The company recently raised $31.5 million in a Series A to grow its team and advance its clinical program.

Led · Series A · Aug 2026

Boom provides an AI-native leasing operating system that combines leasing operations, applicant screening, and rent reporting in one platform. The company launched BoomScreen in mid-2024 and has since introduced BoomCRM, an AI-powered leasing and touring CRM designed to manage the entire leasing funnel from lead capture to tour booking, screening and approval. Boom reports supporting 500K+ rental units and more than 500 operators on its platform, and says its tools reduce response times to seconds and decisions to hours. The product embeds modern large language models across workflows to automate and speed leasing tasks. Boom has attracted both institutional venture investors and strategic operator investors and recently closed a $15M Series A led by S3 Ventures. The company states strong customer momentum and adoption following its product launches.

Participated · Series C · Aug 2026

Versa Vascular is developing the AdapTR transcatheter tricuspid repair device and a delivery platform designed to support native leaflet function while enabling repositioning, implant control, and atrial device positioning to simplify intraprocedural imaging. The company reported positive clinical results and is conducting a first-in-human study outside the U.S. and planning a U.S. Early Feasibility Study. Versa intends to use recent financing to complete those clinical programs and to continue product development and optimization. Leadership changed as part of the update: longtime Medtronic structural heart executive Bill Shields was named CEO, succeeding David Hovda, who will remain as an advisor. Shields brings experience leading transcatheter mitral and tricuspid programs and product development and clinical studies. The article did not disclose revenue, user metrics, founding year, or location.

Led · Series A · Aug 2026

Buzz Solutions offers PowerAI, a platform that transforms inspection imagery into actionable asset intelligence across transmission, distribution, substations and utility-scale solar. The company helps utilities modernize the electric grid by enabling improved reliability, reduced infrastructure risk and optimized maintenance at scale. Leadership includes co-founders and executives Kaitlyn Albertoli (CEO) and Vikhyat Chaudhry (CTO). Buzz Solutions works with utilities across North America, including Dominion Energy, American Electric Power and the New York Power Authority. The company is based in Palo Alto, CA. It plans to use the newly raised Series A funds to accelerate product innovation, expand go-to-market capabilities and deepen customer deployments.

Participated · Series B · Jul 2026

DataBahn provides an agentic data control plane that continuously reduces, enriches, governs and activates telemetry from 600+ sources with neutrality across sources, destinations and AI models. The platform is designed for enterprise scale and security, serving Fortune 500 organizations across industries such as healthcare, financial services, manufacturing and transportation. DataBahn has grown primarily through channel and strategic partners and reports strong commercial metrics, including over 400% year-over-year revenue growth, 180% net revenue retention, zero customer churn, and a 97% proof-of-concept win rate. Headquartered in Dallas, the company emphasizes cost reduction for cloud data movement, storage, compute and AI inference by routing only the data required for real-time operations. Following its Series B, DataBahn plans to invest in R&D and new product capabilities and will preview new functionality at events such as Black Hat USA 2026.